Skip to content
10-Q

Quarterly Report

BioCorRx Inc. BICX

0001477932-24-002923

← back to feed
Filed
May 15, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 14, 2024 9.61M sh
Stockholders Equity Q1 2024 · Mar 31, 2024 −$10.74M
Stockholders Equity Q1 2024 · Dec 31, 2023 −$9.82M
Current Liabilities Q1 2024 · Mar 31, 2024 $7.17M
Current Liabilities Q1 2024 · Dec 31, 2023 $6.43M
Total Liabilities Q1 2024 · Mar 31, 2024 $11.19M
Total Liabilities Q1 2024 · Dec 31, 2023 $10.34M
Current Assets Q1 2024 · Mar 31, 2024 $151.59K
Current Assets Q1 2024 · Dec 31, 2023 $187.12K
Total Assets Q1 2024 · Mar 31, 2024 $317.44K
Total Assets Q1 2024 · Dec 31, 2023 $388.89K
Rd Expense Q1 2024 · Dec 31, 2023 $237.39K
Rd Expense Q1 2024 · Mar 31, 2023 $237.39K
Shares Diluted Q1 2024 · Mar 31, 2023 1.8M sh
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$397.36K
Sga Expense Q1 2024 · Mar 31, 2023 $796.05K
Net Income Q1 2024 · Mar 31, 2023 −$1.01M
Operating Income Q1 2024 · Mar 31, 2023 −$1.06M
Cost Of Revenue Q1 2024 · Mar 31, 2023 $8.68K
Revenue Q1 2024 · Mar 31, 2023 $40.44K